The National Institutes of Health (NIH) is offering this R01 grant to investigate the interplay of autophagy-regulated cell death and HIV pathogenesis in substance use disorders. This grant is for the purpose of exploring how acute and chronic drug use influences central nervous system (CNS) cellular immune responses in HIV-infected individuals. The objective is to deepen understanding of these complex biological interactions and their mechanisms. Proposals should facilitate development of more effective therapeutic and intervention strategies, advancing knowledge at the intersection of neuroimmunology, infectious diseases, and substance abuse to improve health outcomes.
Opportunity ID: 351342
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-25-009 |
Funding Opportunity Title: | Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 06, 2023 |
Last Updated Date: | Dec 06, 2023 |
Original Closing Date for Applications: | Nov 14, 2024 |
Current Closing Date for Applications: | Nov 14, 2024 |
Archive Date: | Dec 20, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education City or township governments Native American tribal governments (Federally recognized) County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The Notice of Funding Opportunity (NOFO) aims to address the interplay of autophagy orchestrated cell death and HIV pathogenesis with a focus on the CNS cellular immune responses influenced by acute and chronic drug use. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-009.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 351342 Full Announcement-RFA-DA-25-009 -> RFA-DA-25-009-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00284053 | Oct 14, 2024 | Nov 14, 2024 | View |
Package 1
Mandatory forms
351342 RR_SF424_5_0-5.0.pdf
351342 PHS398_CoverPageSupplement_5_0-5.0.pdf
351342 RR_OtherProjectInfo_1_4-1.4.pdf
351342 PerformanceSite_4_0-4.0.pdf
351342 RR_KeyPersonExpanded_4_0-4.0.pdf
351342 PHS398_ResearchPlan_5_0-5.0.pdf
351342 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
351342 RR_Budget_3_0-3.0.pdf
351342 RR_SubawardBudget30_3_0-3.0.pdf
351342 PHS398_ModularBudget_1_2-1.2.pdf
351342 PHS_AssignmentRequestForm_3_0-3.0.pdf